Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hayes Dansky

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature|April 11, 2007
Found in translationDavid Shaywitz, Hayes Dansky
Nature Biotechnology|May 8, 2007
Found in translationDavid Shaywitz, Hayes Dansky
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2008
Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitorsJian Shan, Thomas B Nguyen, Hana Totary-Jain, et al.
Circulation|June 28, 2019
Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in HypertriglyceridemiaZahid Ahmad, Poulabi Banerjee, Sara Hamon, et al.
Pharmacoeconomics - Open|June 29, 2019
Symptoms and Dietary Impact in Hypertriglyceridemia-Associated Pancreatitis: Development and Content Validity of Two New MeasuresClaire Burbridge, Jason A Randall, Robert J Sanchez, et al.
Journal of Clinical Lipidology|February 12, 2015
Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trialEliot A Brinton, Uma Kher, Sukrut Shah, et al.
Circulation Research|May 26, 2007
Recipes for creating animal models of diabetic cardiovascular diseaseWilla Hsueh, E Dale Abel, Jan L Breslow, et al.
Journal of the American College of Cardiology|June 4, 2013
Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility studyAhmed Tawakol, Zahi A Fayad, Robin Mogg, et al.
Science Translational Medicine|November 22, 2023
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiencyJudith Y Altarejos, Jeffrey Pangilinan, Simona Podgrabinska, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature|April 11, 2007
Found in translationDavid Shaywitz, Hayes Dansky
Nature Biotechnology|May 8, 2007
Found in translationDavid Shaywitz, Hayes Dansky
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2008
Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitorsJian Shan, Thomas B Nguyen, Hana Totary-Jain, et al.
Circulation|June 28, 2019
Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in HypertriglyceridemiaZahid Ahmad, Poulabi Banerjee, Sara Hamon, et al.
Pharmacoeconomics - Open|June 29, 2019
Symptoms and Dietary Impact in Hypertriglyceridemia-Associated Pancreatitis: Development and Content Validity of Two New MeasuresClaire Burbridge, Jason A Randall, Robert J Sanchez, et al.
Journal of Clinical Lipidology|February 12, 2015
Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trialEliot A Brinton, Uma Kher, Sukrut Shah, et al.
Circulation Research|May 26, 2007
Recipes for creating animal models of diabetic cardiovascular diseaseWilla Hsueh, E Dale Abel, Jan L Breslow, et al.
Journal of the American College of Cardiology|June 4, 2013
Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility studyAhmed Tawakol, Zahi A Fayad, Robin Mogg, et al.
Science Translational Medicine|November 22, 2023
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiencyJudith Y Altarejos, Jeffrey Pangilinan, Simona Podgrabinska, et al.
Pageof 1